• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Guide to (3S)-3-amino-3-cyclohexylpropanoic acid hydrochloride (CAS No. 1956437-96-9)

(3S)-3-amino-3-cyclohexylpropanoic acid hydrochloride (CAS No. 1956437-96-9) is a specialized chiral amino acid derivative that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its cyclohexyl backbone and propanoic acid moiety, serves as a critical building block in drug discovery and peptide synthesis. Its unique structural features make it valuable for modulating biological activity and improving drug delivery systems.

The growing demand for chiral intermediates in the pharmaceutical industry has propelled interest in compounds like (3S)-3-amino-3-cyclohexylpropanoic acid hydrochloride. Researchers are particularly intrigued by its potential applications in designing enzyme inhibitors and receptor modulators, which align with current trends in personalized medicine and targeted therapies. The hydrochloride salt form enhances its solubility, making it more suitable for experimental and industrial applications.

One of the most frequently asked questions about 1956437-96-9 revolves around its synthetic routes and purity standards. High-purity (3S)-3-amino-3-cyclohexylpropanoic acid hydrochloride is essential for reproducible results in bioconjugation and peptide coupling reactions. Analytical techniques such as HPLC and NMR are commonly employed to verify its structural integrity and enantiomeric purity, ensuring compliance with rigorous research protocols.

In the context of green chemistry and sustainable synthesis, (3S)-3-amino-3-cyclohexylpropanoic acid hydrochloride is being explored for its compatibility with eco-friendly reaction conditions. Innovations in catalytic asymmetric synthesis have reduced the environmental footprint of producing such chiral compounds, addressing the pharmaceutical industry's push toward greener alternatives.

Another hot topic is the role of (3S)-3-amino-3-cyclohexylpropanoic acid hydrochloride in prodrug development. Its ability to improve bioavailability and reduce side effects makes it a promising candidate for next-generation therapeutics. Researchers are investigating its incorporation into peptidomimetics and small-molecule drugs, particularly for treating metabolic and neurological disorders.

From a commercial perspective, the global market for fine chemicals like 1956437-96-9 is expanding, driven by advancements in biopharmaceuticals and drug delivery technologies. Suppliers are focusing on scalable production methods to meet the rising demand from academic and industrial laboratories. Quality control, regulatory compliance, and supply chain transparency are key factors influencing procurement decisions.

For researchers seeking reliable data on (3S)-3-amino-3-cyclohexylpropanoic acid hydrochloride, understanding its physicochemical properties is crucial. Parameters such as melting point, solubility profile, and stability under various conditions are frequently searched topics. These properties dictate its handling, storage, and application in experimental settings.

In summary, (3S)-3-amino-3-cyclohexylpropanoic acid hydrochloride (CAS No. 1956437-96-9) represents a versatile and high-value compound in modern chemistry. Its applications span drug development, bioconjugation, and sustainable synthesis, reflecting broader trends in science and technology. As research continues to uncover new uses, this compound is poised to remain a focal point in innovative therapeutic and biochemical solutions.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)